Maryland researchers produce experimental malaria vaccine

University of Maryland School of Medicine researchers have conducted a new study and have produced an experimental vaccine that can protect adults from malaria for more than a year. Read More »

UCLA study tracks funding cuts in PREFAR program

The President’s Emergency Plan for AIDS Relief (PREFAR) has seen a dramatic decrease in funding in critical parts of its budget according to a UCLA study. Read More »

MIT develops new paper-based Zika virus test

MIT researchers have led a team in developing a paper-based test that can diagnose the Zika virus in just a few hours.  Read More »

New HIV infections in the US down, but well short of national goals

Researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health have reported that the number of new HIV infections and the rate of transmission in the United States has dropped by 11 and 17 percent between 2010 and 2015.  Read More »

Meningitis Research Foundation gathers extra support to battle disease

The Meningitis Research Foundation (MRF) acknowledged World Immunization Week by reporting progress in the hands-on training of health care workers in the nation of Malawi and partnerships with global and U.S. initiatives. Read More »

Growth in maternal-child health funding outpaces disease spending

Funding assistance allocated for improving the health of mothers and children in low- and middle-income nations has grown more rapidly over the past six years than has funding for diseases such as HIV, tuberculosis and malaria. Read More »

Scientists discover human (host) protein with strong HIV implications

University of North Carolina School of Medicine and Sanford Burnham Prebys Medical Discovery Institute (SBP) scientists recently announced they have identified a new human (host) protein that potentially weakens the body’s immune response to HIV as well as other viruses. Read More »

Study shows Zika can be transmitted through sexual contact

A study has confirmed that the Zika virus, known to wreak havoc while masked by mild or no symptoms, can be transmitted not only through bites from infected Aedes mosquito but also via sexual contact. Read More »

Oklahoma officials try to track Zika incidents

Oklahoma’s State Department of Health (OSDH) has stepped up its attempts to canvas the state for possible cases of the deadly Zika virus despite the threat level remaining relatively low, officials announced from Oklahoma City recently. Read More »

Despite downward trend, at-risk groups prevent elimination of TB in Europe

In the wake of World TB Day, recently released data from the European Centre for Disease Prevention and Control and WHO/Europe show a surprising number of Europeans developed tuberculosis during 2014. Read More »

Missouri studies examine collaboration between HIV-focused agencies

Two recently published studies by the University of Missouri’s Nidhi Khosla examine cooperation between agencies and organizations serving people with HIV in Baltimore and offer suggestions for improving their services and measuring their collaboration. Read More »

Oxford researchers find new TB biomarkers

Researchers led by Oxford University scientists have identified new biomarkers for tuberculosis that will further our understanding of the variable effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine and aid in the development of new vaccines. Read More »

Researchers study progression of HIV during early stages of infection

Research from several collaborating laboratories, initiated through the Consortium for AIDS Vaccine Research, examined monkeys exposed to Simian Immunovirus infection to determine what happens during the earliest stages of HIV infection in humans. Read More »

Mymetics Corp. HIV vaccine candidate shows potential

A recent study of a Mymetics Corp. HIV vaccine candidate showed that it generated significant protection against repeated AIDS virus exposures in groups of 12 female monkeys. Read More »

Study finds resistance to CRISPR/Cas9 platform when used to target HIV

A recently published study found that the CRISPR/Cas9 gene-editing platform can inhibit viral replication through single mutations, but that viruses that escape the targeted approach become more difficult to target. Read More »

Immunovaccine, Leidos to collaborate on Zika virus vaccine

Clinical stage vaccine producer Immunovaccine Inc. and Leidos, which focuses on national security and infrastructure solutions, will partner to develop a vaccine against Zika virus and infection. Read More »

NIAID begins enrollment in clinical trials of HIV-preventing antibody

Researchers recently began enrollment for the first of two multinational clinical trials, known as the AMP Studies, which are sponsored by the National Institute of Allergy and Infectious Diseases and could provide a safe, tolerable and effective way to prevent HIV infection. Read More »

African Union discusses governmental response to Ebola outbreak

The African Union Department of Social Affairs recently held a high-level round table on governance issues in the various responses to the Ebola virus, focusing on the lessons learned and the best practices for resilient health systems moving forward. Read More »

German researchers find no benefit to use of rilpivirine on HIV children and adolescents.

BodyThe German Institute for Quality and Efficiency in Health Care (IQWiG) recently found that there is no proven added benefit for HIV-1 infected children and adolescents treated with rilpivirine as opposed to the appropriate comparator therapy. Read More »

Study suggests modified cholesterol can inhibit growth of drug-resistant tuberculosis

Researchers from the University of Queensland and University of California San Francisco have found that modified cholesterol can inhibit the growth of the bacterium that causes tuberculosis, a disease that claims a life every 21 seconds. Read More »